Successful intra-arterial fibrinolysis of the anterior choroidal artery in the acute stage of internal carotid artery occlusion: case report

Clinical importance of the anterior choroidal artery: a review of the literature

The anterior choroidal artery (AChA) is a critical artery in brain physiology and function. The AChA is involved in many diseases, including aneurysm, brain infarct, Moyamoya disease (MMD), brain tumor, arteriovenous malformation (AVM), etc. The AChA is vulnerable to damage during the treatment of these diseases and is thus a very important vessel. However, a comprehensive systematic review of the importance of the AChA is currently lacking. In this study, we used the PUBMED database to perform a literature review of the AChA to increase our understanding of its role in neurophysiology. Although the AChA is a small thin artery, it supplies an extremely important region of the brain. The AChA consists of cisternal and plexal segments, and the point of entry into the choroidal plexus is known as the plexal point. During treatment for aneurysms, tumors, AVM or AVF, the AChA cisternal segments should be preserved as a pathway to prevent the infarction of the AChA target region in the brain. In MMD, a dilated AChA provides collateral flow for posterior circulation. In brain infarcts, rapid treatment is necessary to prevent brain damage. In Parkinson disease (PD), the role of the AChA is unclear. In trauma, the AChA can tear and result in intracranial hematoma. In addition, both chronic and non-chronic branch vessel occlusions in the AChA are clinically silent and should not deter aneurysm treatment with flow diversion. Based on the data available, the AChA is a highly essential vessel.

Mechanical Intracranial Embolectomy

Cerebral ischaemia due to thrombo-embolic complications of intracranial endovascular therapy remains one of the more obvious hazards of this otherwise rather gentle treatment. In this connection the time factor is usually well controlled and the possibility to achieve a good result from thrombolysis are possibly better7. To directly extract an embolus mechanically would be an attractive alternative.

This has so far been hampered by the lack of suitable tools. The use of a microsnare intended for intravascular retrieval of foreign bodies like displaced coils or broken catheters shown here must further encourage development of specially designed “thrombectomy devices” for intracranial use. Such a tool may well have an impact on the treatment of noniatrogenic emboli as well.

Evaluation of time-dependent thresholds of cerebral blood flow and transit time during the acute stage of cerebral embolism: a retrospective study

BACKGROUND

Neurons within the ischemic penumbra are thought to be in a potentially reversible state of ischemic challenge. One therapeutic approach that is being actively explored is the recovery of function of cells within the ischemic penumbra through endovascular recanalization of cerebral arteries occluded with embolus. The purpose of this study was to determine the time-dependent hemodynamic threshold for the prevention of irreversible ischemia in patients with acutely symptomatic internal and middle cerebral artery (MCA) embolism.

METHODS

Thirty-six patients admitted within 6 hours of the onset of symptoms of acute cerebral ischemia, due to embolic occlusion of the major trunk of one of the arteries of the anterior cerebral circulation, were studied. On admission, both cerebral blood flow (CBF) and mean transit time (MTT) measurements were obtained following plain computed tomography (CT). All patients were treated by intraarterial administration of urokinase. MTT in the territory of the affected MCA divided by that in the territory of the unaffected MCA was defined as %MTT.

RESULTS

A significant negative correlation was found between MTT and CBF. In patients with at least 19 mL/100 g/minute CBF and a maximum of 1.6 %MTT, no cortical infarction occurred whether or not recanalization was obtained. Cortical infarction did not appear in patients with 9 mL/100 g/minute residual CBF and infinite %MTT in whom recanalization was achieved within 2 hours of onset, in patients with 13 mL/100 g/minute residual CBF and 3.7 %MTT in whom recanalization was achieved within 2.5 hours of onset, and in patients with 14 mL/100 g/minute residual CBF and 2.8 %MTT in whom recanalization could be achieved within 3.5 hours of onset.

CONCLUSIONS

CBF and MTT thresholds for conversion of reversible to irreversible ischemia can be rapidly determined by CT-based technologies. This type of information should be clinically relevant to guiding the management of patients with cerebral embolism.